durapatite has been researched along with folic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashokan, A; Koyakutty, M; Menon, D; Nair, S | 1 |
| Kumar, J; Ramasamy, S; Reddy, GP; Venkatasubbu, GD | 1 |
| Chen, X; Chen, Y; Li, S; Ping, Q; Shi, Y; Su, Z; Sun, M; Xiao, Y; Zong, L | 1 |
| Kanchana, P; Sekar, C | 1 |
| Carbajal Arízaga, GG; Gurinov, A; Ortiz, GG; Pacheco Moisés, FP; Sánchez Lafarga, AK | 1 |
| Almeida, MM; Costa, ME; Duarte, JA; Fernandes, MH; Gomes, P; Santos, C | 1 |
| Liu, P; Ma, X; Tian, Y; Wang, G; Yang, L; Yang, P; Zhu, G | 1 |
| Du, J; Fan, J; Kang, Y; Peng, X; Sun, W; Wang, S | 1 |
| Li, B; Li, H; Li, Y; Liang, C; Sun, X; Wang, H | 1 |
| Hassan, PA; Pandey, BN; Pandrekar, S; Priyadarsini, KI; Shetake, NG; Verma, G | 1 |
| Ansari, L; Bagheri, E; Derakhshi, M; Malaekeh-Nikouei, B; Shahtahmassebi, N | 1 |
| Liu, C; Ma, X; Qian, J; Sha, D; Yuan, Y; Zhang, S | 1 |
12 other study(ies) available for durapatite and folic acid
| Article | Year |
|---|---|
A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.
Topics: Animals; Carrier Proteins; Cell Line; Contrast Media; Crystallography, X-Ray; Durapatite; Endothelial Cells; Flow Cytometry; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Infrared Rays; Magnetic Resonance Spectroscopy; Magnetics; Mice; Microscopy, Fluorescence; Molecular Imaging; Nanoparticles; Neoplasms; Particle Size; Polyethyleneimine; Receptors, Cell Surface; Spectrometry, Fluorescence; Umbilical Veins; Vibration | 2010 |
In vitro and in vivo anticancer activity of surface modified paclitaxel attached hydroxyapatite and titanium dioxide nanoparticles.
Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Carriers; Durapatite; Folic Acid; Hematologic Tests; Hep G2 Cells; Humans; Liver Neoplasms; Male; Nanoparticles; Paclitaxel; Polyethylene Glycols; Rats; Rats, Wistar; Surface Properties; Titanium; Xenograft Model Antitumor Assays | 2013 |
Multistep targeted nano drug delivery system aiming at leukemic stem cells and minimal residual disease.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Line, Tumor; Drug Delivery Systems; Durapatite; Folic Acid; Humans; Leukemia; Leukocytes; Mice; Mitoxantrone; Neoplasm, Residual; Neoplastic Stem Cells; Polyethylene Glycols; Rats | 2013 |
Development of electrochemical folic acid sensor based on hydroxyapatite nanoparticles.
Topics: Durapatite; Electrochemical Techniques; Folic Acid; Limit of Detection; Nanoparticles; Pharmaceutical Preparations; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman | 2015 |
Dual responsive dysprosium-doped hydroxyapatite particles and toxicity reduction after functionalization with folic and glucuronic acids.
Topics: Animals; Durapatite; Dysprosium; Folic Acid; Glucuronic Acid; Magnetic Resonance Imaging; Microscopy, Fluorescence; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2015 |
Development of hydroxyapatite nanoparticles loaded with folic acid to induce osteoblastic differentiation.
Topics: Alkaline Phosphatase; Bone Regeneration; Cell Differentiation; Cell Proliferation; Cells, Cultured; Citric Acid; Durapatite; Folic Acid; Humans; Mesenchymal Stem Cells; Nanoparticles; Osteoblasts | 2017 |
A mineralized cell-based functional platform: construction of yeast cells with biogenetic intracellular hydroxyapatite nanoscaffolds.
Topics: Animals; Cytoplasm; Doxorubicin; Drug Carriers; Drug Liberation; Durapatite; Folic Acid; Hep G2 Cells; Humans; Mice, Nude; Nanoparticles; Neoplasms, Experimental; Saccharomyces cerevisiae; Xenograft Model Antitumor Assays | 2018 |
Biodegradable Drug-Loaded Hydroxyapatite Nanotherapeutic Agent for Targeted Drug Release in Tumors.
Topics: Animals; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Folic Acid; Mice; Neoplasms | 2018 |
Preparation and properties of carbon nanotube (Fe)/hydroxyapatite composite as magnetic targeted drug delivery carrier.
Topics: Antineoplastic Agents; Chitosan; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Folic Acid; Hydrogen-Ion Concentration; Iron; Magnets; Microscopy, Electron, Scanning; Nanotubes, Carbon; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2019 |
Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Drug Delivery Systems; Durapatite; Folic Acid; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; KB Cells; Mice; Nanoparticles; Neoplasms | 2020 |
Folate conjugation improved uptake and targeting of porous hydroxyapatite nanoparticles containing epirubicin to cancer cells.
Topics: Animals; Antibiotics, Antineoplastic; Biocompatible Materials; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Durapatite; Epirubicin; Female; Folic Acid; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanoparticles; Particle Size; Polyethylene Glycols; Porosity | 2020 |
A novel strategy for tumor therapy: targeted, PAA-functionalized nano-hydroxyapatite nanomedicine.
Topics: Acrylic Resins; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Durapatite; Folic Acid; Humans; Nanomedicine; Nanoparticles; Neoplasms | 2020 |